Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01678157 · ClinicalTrials.gov registry record
Use of Strattice Mesh in Paraesophageal Hernia Surgery
A clinical trial, sponsored by University of Nebraska.
- Completed
- Registry status
- 35
- Enrollment target
NCT01678157: Completed study, sponsored by University of Nebraska.
NCT01678157 is a clinical trial that has completed, run by University of Nebraska. The registered enrollment target is 35 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01678157 has completed, sponsored by University of Nebraska.
- COMPLETED
- Registry status
- 35 participants
- Enrollment target
Study Summary
The objective of this study is to examine the safety and efficacy of porcine acellular dermal matrix mesh (Strattice; LifeCell Corp., Branchburg, NJ) in crural reinforcement of laparoscopic large paraesophageal hernia repair.
Primary Outcome
A barium swallow test with x-rays will be performed to assess recurrence of hernia, if any
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2012-03-05 |
| Est. Completion | 2015-05-01 |
What the finished NCT01678157 record still lists
NCT01678157 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 35 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01678157 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01678157 about?
NCT01678157 is a clinical study titled "Use of Strattice Mesh in Paraesophageal Hernia Surgery". The objective of this study is to examine the safety and efficacy of porcine acellular dermal matrix mesh (Strattice; LifeCell Corp., Branchburg, NJ) in crural reinforcement of laparoscopic large paraesophageal hernia repair.
What is the current status of trial NCT01678157?
This trial is currently completed. The enrollment target is 35 participants. The study started on 2012-03-05. Estimated completion is 2015-05-01.
Who is sponsoring clinical trial NCT01678157?
This trial is sponsored by University of Nebraska, which has 407 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01697371 · 35 participants · NA
Proton Therapy in the Treatment of Liver Metastases
- NCT01940757 · 35 participants · Phase 1
Experimental Infection of Hookworm-naïve Adults With Dermally-applied Infectious Necator Americanus Hookworm Larvae
- NCT02235857 · 35 participants · NA
Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children
- NCT02637934 · 35 participants · Phase 1
Phase I Pilot Study of Biodistribution, Metabolism and Excretion of Novel Radiotracer [18F]Fluorthanatrace (FTT) by PET/CT
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI